Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza.

John A. Vanchiere,Stephanie Plunkett,Rajasekaran Annamalai,Katie Julien,James Peterson,Marcy Goisse,Shane Christensen,Priyesh Mehta,Stephen Coleman,Flor M. Munoz,Amy Flynt,Sylvia Dobo,Eniko Nagy,Deborah Kargl,Amanda Mathis,Phil Collis,William Sheridan

Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza.

2017

John A. Vanchiere
Stephanie Plunkett
Rajasekaran Annamalai
Katie Julien
James Peterson
Marcy Goisse
Shane Christensen
Priyesh Mehta
Stephen Coleman
Flor M. Munoz
Amy Flynt
Sylvia Dobo
Eniko Nagy
Deborah Kargl
Amanda Mathis
Phil Collis
William Sheridan

Background Peramivir (PVR) is a potent neuraminidase inhibitor with in vitro activity against all influenza virus subtypes. Previous studies demonstrated the efficacy and safety of PVR as a single dose intravenous (IV) treatment for acute uncomplicated influenza in adults.

Keywords:

Peramivir
Intensive care medicine
Medicine
Virus
Viral shedding
Neuraminidase inhibitor
Virology
Pharmacology
Viral culture
Vomiting
single dose regimen
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations